Cargando…
Neuroinflammation in the pathogenesis of Alzheimer’s disease. A rational framework for the search of novel therapeutic approaches
Alzheimer disease (AD) is the most common cause of dementia in people over 60 years old. The molecular and cellular alterations that trigger this disease are still diffuse, one of the reasons for the delay in finding an effective treatment. In the search for new targets to search for novel therapeut...
Autores principales: | Morales, Inelia, Guzmán-Martínez, Leonardo, Cerda-Troncoso, Cristóbal, Farías, Gonzalo A., Maccioni, Ricardo B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4001039/ https://www.ncbi.nlm.nih.gov/pubmed/24795567 http://dx.doi.org/10.3389/fncel.2014.00112 |
Ejemplares similares
-
Tau Oligomers as Potential Targets for Alzheimer’s Diagnosis and Novel Drugs
por: Guzmán-Martinez, Leonardo, et al.
Publicado: (2013) -
Scaling the Andean Shilajit: A Novel Neuroprotective Agent for Alzheimer’s Disease
por: Andrade, Víctor, et al.
Publicado: (2023) -
Neuroinflammation as a Common Feature of Neurodegenerative Disorders
por: Guzman-Martinez, Leonardo, et al.
Publicado: (2019) -
Revisiting the neuroinflammation hypothesis in Alzheimer’s disease: a focus on the druggability of current targets
por: Wong-Guerra, Maylin, et al.
Publicado: (2023) -
Alzheimer’s Disease and Tau Self-Assembly: In the Search of the Missing Link
por: González, Andrea, et al.
Publicado: (2022)